ARCHIVES

FDA: Oncology Division Director Delap Promoted In Agency

This article is from The Cancer Letter archive.

Vol. 24 No. 21 | May 29, 1998

Download PDF Visit The Full Archive

Related Articles

USC Study Finds Increased Colon Cancer Risk For Sedentary Workers

April 13, 1984

Four Patients In Tamoxifin Treatment Trial Had Died of Uterine Cancer Prior To BCPT

April 29, 1994

FDA Approves Imaging Agent For Recurrent Prostate Cancer

September 28, 2012

Clearinghouse Agrees On Three Big New Carcinogens

May 4, 1979

ODAC Recommends Taxol For Metastatic Breast Cancer

January 7, 1994

House Committee Seeks Review Of Indirect Costs Of NIH Grantees

July 25, 2013